Protein Sciences Struggles For Market Share Of Flu Vaccine

Almost four years after Protein Sciences began selling its innovative flu vaccine, the Meriden company still struggles to gain a foothold in a marketplace dominated by pharmaceutical powerhouses. Orders for Flublok – the only flu vaccine not derived from eggs – remain well below company goals, and officials haven’t been able to get it into some major pharmacy chains such as CVS and Walgreens. “We’re doing better than last year, but we’re still not doing as well as I would like to do,” said CEO Manon Cox. The company aims to sell 900,000 doses of Flublok by the end of the current flu season in late March, she said. So far, it has sold just 250,000, even as widespread flu outbreaks spread across several parts of the country.

C-HIT Chosen For Knight News Match

In a move intended to underscore the growing importance of independent, in-depth journalism, the Knight Foundation has launched an end-of-year program that will match donations to C-HIT and select other nonprofit news organizations. Dubbed the Knight News Match, the program will match donations from individual donors to C-HIT and 56 other news groups nationwide, up to a total of $1.5 million, through Jan.19. Individual organizations are eligible to receive up to $25,000 in matching funds. “News Match is a call to action for everyone who believes in quality, trustworthy, in-depth journalism and the role nonprofit news organizations play in building strong communities,” the Knight Foundation said in announcing the program. “Successful journalism organizations need a passionate, dedicated community of supporters.